Francisco Javier
Bachiller Corral
Profesor/a Asociado/a en CC. de la Salud
Hospital Ramón y Cajal
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (65)
2024
-
Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank
Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287
-
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: A post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial
Journal of Bone and Mineral Research, Vol. 39, Núm. 10, pp. 1486-1492
-
Quality of life of patients with rheumatic diseases
Reumatologia Clinica, Vol. 20, Núm. 2, pp. 59-66
-
Successful treatment of AA amyloidosis with tocilizumab, resulting in the disappearance of amyloid deposits: a case-based review
Egyptian Rheumatology and Rehabilitation, Vol. 51, Núm. 1
-
Toward Telemonitoring in Immune-Mediated Inflammatory Diseases: Protocol for a Mixed Attention Model Study
JMIR Research Protocols, Vol. 13, Núm. 1
2023
-
Evaluating remission and low disease activity from the perspective of the patient with axial spondyloarthritis: The cross-sectional ConREspAx study
Joint Bone Spine, Vol. 90, Núm. 2
-
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
Nature Medicine, Vol. 29, Núm. 10, pp. 2615-2624
-
Myositis autoantibodies detected by line blot immunoassay: clinical associations and correlation with antibody signal intensity
Rheumatology International, Vol. 43, Núm. 6, pp. 1101-1109
-
Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry
Modern rheumatology, Vol. 34, Núm. 1, pp. 97-105
2022
-
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
Clinical and experimental rheumatology, Vol. 40, Núm. 2, pp. 274-283
-
Low Positivity Rate of Anti-SARS-CoV-2 IgG in Unvaccinated Patients With Rheumatic Diseases Treated With Rituximab
Journal of Clinical Rheumatology, Vol. 28, Núm. 8, pp. 424-428
-
Retention rate of secukinumab in psoriatic arthritis: Real-world data results from a Spanish multicenter cohort
Medicine (United States), Vol. 101, Núm. 36, pp. E30444
2021
-
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up
Rheumatology (Oxford, England), Vol. 60, Núm. 6, pp. 2906-2915
-
Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases
Pediatric Rheumatology, Vol. 19, Núm. 1
-
Development of Iatrogenic Cushing Syndrome after Peri-articular Glucocorticoid Injection in an Human Immunodeficiency Virus Patient on Protease Inhibitor Therapy
Journal of Clinical Rheumatology
-
Factors associated with COVID-19-related death in people with rheumatic diseases: Results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Annals of the Rheumatic Diseases, Vol. 80, Núm. 7, pp. 930-942
-
Remission Induced by TNF Inhibitors Plus Methotrexate is Associated With Changes in Peripheral Naïve B Cells in Patients With Rheumatoid Arthritis
Frontiers in Medicine, Vol. 8
-
Rheumatoid meningitis as a complication of long-standing rheumatoid arthritis: a case treated with rituximab
Modern Rheumatology Case Reports, Vol. 5, Núm. 2, pp. 200-205
-
Risk of severe COVID-19 infection in patients with inflammatory rheumatic diseases
Journal of Rheumatology, Vol. 48, Núm. 7, pp. 1098-1102
2020
-
Association of apolipoprotein B/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: results of the CARMA study
Clinical and experimental rheumatology, Vol. 38, Núm. 4, pp. 662-669